Sarepta Therapeutics (SRPT) Net Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.60% |
| Mar 31, 2026 | -74.51% |
| Dec 31, 2025 | 45.86% |
| Sep 30, 2025 | 21.11% |
| Jun 30, 2025 | 33.06% |
| Mar 31, 2025 | -23.97% |
| Dec 31, 2024 | 52.36% |
| Sep 30, 2024 | -17.30% |
| Jun 30, 2024 | -20.57% |
| Mar 31, 2024 | -14.91% |
| Dec 31, 2023 | -22.21% |
| Sep 30, 2023 | -9.08% |
| Jun 30, 2023 | 33.07% |
| Mar 31, 2023 | -17.50% |
| Dec 31, 2022 | -31.98% |
| Sep 30, 2022 | -17.61% |
| Jun 30, 2022 | -27.36% |
| Mar 31, 2022 | -50.77% |
| Dec 31, 2021 | 31.26% |
| Sep 30, 2021 | -18.60% |